These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17654209)

  • 21. Vesical and vaginal recurrent endometriosis in postmenopause following estrogen replacement therapy.
    Sesti F; Vettraino G; Pietropolli A; Marziali M; Piccione E
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):265-6. PubMed ID: 15653219
    [No Abstract]   [Full Text] [Related]  

  • 22. What have we really learned from 'LIBERATE' trial?
    Dimitrakakis C; Tsigginou A; Keramopoulos D; Antsaklis A
    Maturitas; 2010 May; 66(1):99-100. PubMed ID: 20236777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of hormone treatment on hemostasis variables.
    Kluft C
    Climacteric; 2007 Oct; 10 Suppl 2():32-7. PubMed ID: 17882670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tibolone-induced hepatotoxicity].
    Blanco Sampascual S; de Las Heras Niño B; Cabezudo Gil P; Ruiz Eguiluz P; Orive Cura V
    Gastroenterol Hepatol; 2002 Apr; 25(4):274. PubMed ID: 11975880
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term effects of tibolone on ocular functions in postmenopausal women.
    Verit FF; Oguz H; Ozkul Y; Bozkurt O
    Arch Gynecol Obstet; 2007 Apr; 275(4):255-61. PubMed ID: 17047975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tibolone, blood pressure and obesity.
    Roshan J; Ganesh A
    Natl Med J India; 2002; 15(3):180. PubMed ID: 12186341
    [No Abstract]   [Full Text] [Related]  

  • 27. Tibolone reduces osteoporotic fracture risk and breast cancer risk, but increases the risk of stroke.
    de Melo NR; Pompei LM
    Gynecol Endocrinol; 2010 Feb; 26(2):73-5. PubMed ID: 19995151
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator.
    Campisi R; Marengo FD
    Cardiovasc Drug Rev; 2007; 25(2):132-45. PubMed ID: 17614936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Million Women Study--is it believable?
    Farmer R
    Climacteric; 2005 Sep; 8(3):210-3. PubMed ID: 16390752
    [No Abstract]   [Full Text] [Related]  

  • 30. Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.
    Nas T; Sargon MF; Celik HH; Keskin PO; Gürsoy RH; Biberoglu K
    Saudi Med J; 2007 Dec; 28(12):1917-9. PubMed ID: 18060233
    [No Abstract]   [Full Text] [Related]  

  • 31. E-cadherin expression in cervical epithelial cells of postmenopausal women: association with hormone therapy, tibolone, and raloxifene.
    Sioulas V; Christodoulakos G; Lambrinoudaki I; Politi E; Sergentanis TN; Creatsas G
    Fertil Steril; 2008 Apr; 89(4):1018-20. PubMed ID: 17689538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. By the way, doctor. What happened to tibolone--the estrogen alternative we heard about a while ago? Did it turn out not to be effective?
    Robb-Nicholson C
    Harv Womens Health Watch; 2004 Apr; 11(8):8. PubMed ID: 15100062
    [No Abstract]   [Full Text] [Related]  

  • 33. Exacerbation of adenomyosis in a postmenopausal woman taking tibolone associated with an elevation in serum CA 125.
    Davies AP; Oram D
    Br J Obstet Gynaecol; 1994 Jul; 101(7):632-3. PubMed ID: 8043545
    [No Abstract]   [Full Text] [Related]  

  • 34. Tibolone revisited: still a good treatment option for healthy, early postmenopausal women.
    Kenemans P
    Gynecol Endocrinol; 2010 Apr; 26(4):237-9. PubMed ID: 20017707
    [No Abstract]   [Full Text] [Related]  

  • 35. Endometriosis arising during estrogen and testosterone treatment 17 years after abdominal hysterectomy: a case report.
    Goumenou AG; Chow C; Taylor A; Magos A
    Maturitas; 2003 Nov; 46(3):239-41. PubMed ID: 14585528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaginal polyps and hormones--is there a link? A case series.
    Sharma S; Albertazzi P; Richmond I
    Maturitas; 2006 Feb; 53(3):351-5. PubMed ID: 16029937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
    Diaby V; Perreault S; Lachaine J
    Maturitas; 2007 Oct; 58(2):138-49. PubMed ID: 17870259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tibolone-induced acute hepatitis: Well-known drug, little-known complication.
    Macedo G; Silva M; Vilas-Boas F; Lopes S; Peixoto A; Carneiro F
    Gastroenterol Hepatol; 2017 Apr; 40(4):298-300. PubMed ID: 27093896
    [No Abstract]   [Full Text] [Related]  

  • 39. Hormone replacement therapy use and the risk of stroke.
    Renoux C; Dell'aniello S; Garbe E; Suissa S
    Maturitas; 2008 Dec; 61(4):305-9. PubMed ID: 18996656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tibolone: the risk is too high.
    Goodwin PJ
    Lancet Oncol; 2009 Feb; 10(2):103-4. PubMed ID: 19185829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.